持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2011/07/15 | 日証協 | 173,711株 | +1.16% | 37,000株 | +37.04% | 311,692株 | -3.41% | 11,000株 | -52.17% |
2011/07/08 | 日証協 | 171,711株 | +3% | 27,000株 | +8% | 322,692株 | 0% | 23,000株 | -30.3% |
2011/07/01 | 日証協 | 166,711株 | -3.47% | 25,000株 | +20.45% | 322,692株 | +51.72% | 33,000株 | -61.18% |
2011/06/24 | 日証協 | 172,711株 | -13.26% | 20,755株 | -67.66% | 212,692株 | -29.12% | 85,000株 | +56.25% |
2011/06/17 | 日証協 | 199,111株 | +0.2% | 64,175株 | +34.64% | 300,092株 | -9.25% | 54,400株 | -58.47% |
2011/06/10 | 日証協 | 198,711株 | +5.86% | 47,665株 | +25.4% | 330,692株 | -1.78% | 131,001株 | +7.82% |
2011/06/03 | 日証協 | 187,711株 | +1.08% | 38,010株 | -64.31% | 336,691株 | +7.68% | 121,500株 | +228.38% |
2011/05/27 | 日証協 | 185,711株 | -1.59% | 106,510株 | +189.78% | 312,691株 | -0.64% | 37,000株 | -78.36% |
2011/05/20 | 日証協 | 188,711株 | -7.82% | 36,755株 | -39.75% | 314,691株 | +19.8% | 171,000株 | +205.36% |
2011/05/13 | 日証協 | 204,711株 | +5.68% | 61,000株 | +258.82% | 262,691株 | +1.94% | 56,000株 | +86.67% |
2011/05/06 | 日証協 | 193,711株 | -11.83% | 17,000株 | -84.11% | 257,691株 | +1.18% | 30,000株 | +30.43% |
2011/04/28 | 日証協 | 219,711株 | -4.77% | 107,000株 | +4.9% | 254,691株 | -21.07% | 23,000株 | -70.13% |
2011/04/22 | 日証協 | 230,711株 | +3.09% | 102,000株 | -21.94% | 322,691株 | -0.92% | 77,000株 | -1.28% |
2011/04/15 | 日証協 | 223,792株 | -14.88% | 130,672株 | -14.94% | 325,702株 | -0.96% | 78,000株 | -17.53% |
2011/04/08 | 日証協 | 262,924株 | +11.82% | 153,627株 | +104.19% | 328,854株 | -6.96% | 94,581株 | -39.15% |
2011/04/01 | 日証協 | 235,133株 | -2.69% | 75,236株 | -57.33% | 353,453株 | -14.63% | 155,430株 | +12.14% |
2011/03/25 | 日証協 | 241,633株 | -2.58% | 176,336株 | -8.63% | 414,033株 | -2.75% | 138,600株 | -3.02% |
2011/03/18 | 日証協 | 248,033株 | -3.03% | 193,000株 | +93% | 425,754株 | +4.98% | 142,920株 | +142.24% |
2011/03/11 | 日証協 | 255,788株 | -20.51% | 100,000株 | -54.7% | 405,570株 | -5.58% | 59,000株 | -38.4% |
※株式分割は考慮していませんのでご注意ください。
Page Top